Treatment of type 1 diabetes: Synopsis of the 2017 American Diabetes Association standards of medical care in diabetes

James J. Chamberlain, Rita R. Kalyani, Sandra Leal, Andrew S. Rhinehart, Jay H. Shubrook, Neil Skolnik, William H. Herman

Research output: Contribution to journalArticlepeer-review

Abstract

Description: The American Diabetes Association (ADA) annually updates Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes. Methods: For the 2017 Standards of Care, the ADA Professional Practice Committee did MEDLINE searches from 1 January 2016 to November 2016 to add, clarify, or revise recommendations on the basis of new evidence. The committee rated the recommendations as A, B, or C, depending on the quality of evidence, or E for expert consensus or clinical experience. The Standards of Care were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions. Recommendation: This synopsis focuses on recommendations from the 2017 Standards of Care about monitoring and pharmacologic approaches to glycemic management for type 1 diabetes.

Original languageEnglish (US)
Pages (from-to)493-498
Number of pages6
JournalAnnals of Internal Medicine
Volume167
Issue number7
DOIs
StatePublished - Oct 3 2017

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Treatment of type 1 diabetes: Synopsis of the 2017 American Diabetes Association standards of medical care in diabetes'. Together they form a unique fingerprint.

Cite this